Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2026-01-27 @ 11:05 PM
Study NCT ID:
NCT00412503
Status:
COMPLETED
Last Update Posted:
2009-08-07
First Post:
2006-12-15
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Temozolomide in Association With Topotecan in Refractory or Relapsed Malignant Tumors in Children and Adolescents
Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CSET 1197
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None